Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The present invention is also particularly suitable for use for biodegradable personal care products, such as diapers, training pants, feminine tampons, pads and pantiliners, and baffle films therefor, adult incontinence products, wet wipes and/or wipers and any woven, non-woven, or otherwise formed materials
http://www.patentstorm.us/patents/7053151/fulltext.html
DC,take a guess on the amount of $$ these majors spend a year alone on R&D for green products?
My guess millions a year.
For a few dollars more they could of had CES's tech!!
Did they miss what you are getting all bent of of shape about.
DC,Biodegradable Polymers and Plastics is new to you but not the major players..lol here's more old stuff
http://www.wtec.org/pdf/biopoly.pdf
http://www.allbusiness.com/chemicals/plastics-rubber-industry-resins-thermoplastics/8086770-1.html
http://www.allbusiness.com/chemicals/plastics-rubber-industry-resins-thermoplastics/7812745-1.html
http://www.acfnewsource.org/environment/eco-plastic.html
Business activities with Shazil, relating to the distribution agreement, are currently dormant. Although the agreement is still in effect, the Company has not received any subsequent orders from Shazil, nor does it expect to receive any additional orders in the immediate future. The Company and Shazil have not discussed additional orders in 2004 as the Company has focused its attention on the North American market.
getting a better understanding of what PYCT just got
The Company also wishes to clarify a previously reported statement that "flushawayTM continues to flourish at Boots, Sainsburys and Waitrose." This statement was based on U.K. sales of approximately $169,000 in the preceding 5 quarters ended September 30, 2003. While a decline was noticed in the quarter preceding the news release, the Company believed sales would be sustainable. Subsequently, sales for the U.K. continued to decline.
Clarification of News Release dated April 26, 2004
The Company previously reported that the flushawayTM brand of feminine hygiene products was being piloted at a major U.S. retailer with more than 3,000 stores. The U.S. retailer that participated in the pilot program was an entity other than Wal Mart. The identity of the retailer has not been disclosed as the Company has not obtained consent from the retailer. The pilot program was conducted solely by Premier and was a one-time event achieving mixed results. The Company also reported that "recent critical testing by an independent U.S. laboratory indicates flushawayTM is ready for the U.S. market and capable of competing". The Company wishes to report that the entity that performed the independent testing was Shuster Laboratories, Inc. of Canton, Massachusetts, U.S.A, an independent testing laboratory.
Clarification of News Release dated June 2, 2004
U.K. Sales Listings
The Company has recently been verbally advised that its flushawayTM product is no longer being stocked for sale in the Boots and Sainsburys stores in the U.K. The Company is continuing negotiations with Boots to maintain its listing. The Company's product is still sold in Waitrose stores in the U.K. The Company will continue to develop its flushawayTM product and will continue to pursue placing its flushawayTM product in various retailers in the U.K.
they sold 50000$ worth of pads for 1700 stores...do the math
This C$50,000 order, for one container of Flushaway, is expected to be the first in a series of orders from Dr. Fresh. The shipment will comprise 1500 cases of liners and 900 cases of pads.
Distribution of this order will be through more than 1700 Wal-Mart stores that stock Flushaway where, according to Dr. Fresh, shelf sales have recently been increasing.
Clarification of News Release dated August 18, 2004
The Company previously reported that Dr. Fresh submitted a second order for the Company's flushawayTM product to be shipped to Wal Mart. Pursuant to this re-order, Dr. Fresh acquired 1,690 cases for total sales to the Company of CDN$30,000. The second order is expected to be produced and shipped by the end of October 2004. The Company wishes to report that the distribution of it's flushawayTM product remains at approximately 45% of participating Wal Mart stores.
DC...check this
http://newsblaze.com/story/2006042811241700003.mwir/topstory.html
You can imagine the excitement CES shareholder had when reading PR's like link above..problem was it was just talk nothing happenned there was no repeat orders.
Walmart didn't delist them for no reason,they didn't sell!!
VANCOUVER, British Columbia -- Consolidated Ecoprogress Technology Inc. (TSX VENTURE:CES) is pleased to announce a re-order from Dr. Fresh for the latest version of its Flushaway product.
This C$50,000 order, for one container of Flushaway, is expected to be the first in a series of orders from Dr. Fresh. The shipment will comprise 1500 cases of liners and 900 cases of pads.
Distribution of this order will be through more than 1700 Wal-Mart stores that stock Flushaway where, according to Dr. Fresh, shelf sales have recently been increasing.
hey DC all these links you post?
What they have to do with PYCT...like this one show me whats what you read thats revelant.
http://sustainablog.org/2008/02/04/wal-marts-company-of-the-future-some-final-thoughts/
and here
http://www.csrwire.com/pdf/WMT_Sustainability_4-06
Fact still remains Walmart did delist CES's Napkins
http://www.flushaway.com/news/pdf/ces_2006-0803_nr.pdf
"Don't worry about where the funding is coming from it is well taken care of"
Ahhh do u have inside info for this post or u been speaking to IR?
The market has spoken 3 PR and you got squat on the upside.
Fact is they got no money to move forward!!
Announce that officially and you got action on the upside.
This is an old old story and all that has happenned is move from the TSX to the Pinks for a new round of hype.
I already feel the excitement created with the 34BILLION$ market story...lol
again a major player would be all over this...years ago
dcjr,as u could read they had production issues.With no money these issues still exsist for PYCT.Money will be needed to fix those issues before production commences.
Money will have to come from insiders or PP...Forget Bankloans/line of credit or chinesse 75Day nets unless you are a major like a Walmart.
Cons Ecoprogress works to restart Flushaway production 2007-10-25 20:42 ET - News Release Mr. John Banks reports RE-COMMENCING MANUFACTURING NEARS Consolidated Ecoprogress Technology Inc.'s progress has continued with API reviewing production and meeting with Asian manufacturers both in North America and in China. Existing and potential future manufacturers of Flushaway have held discussions to resolve certain production issues and streamline the production process. The complexities of both the formula for Flushaway and the production process have created the delays in restarting production. The company is close to finalizing both the nanotech formula and production process, and a news release will be issued when a definitive timeline is set. To date, API has advanced us a $50,000 down payment as a goodwill gesture, which has been taken as payment for the sales and marketing agreement and the manufacturing agreement. The remaining cash component and the $5-million note receivable have not yet closed. The terms of the note are being finalized and proceeds are to be received over a five-year period. The receipt of the final money and note payable from API is anticipated at the completion of the handover of the Flushaway intellectual property and the completion of the final validation and acceptance sign-off by API. The company's research partner, Quartek Corporation of North Carolina, has continued to support Flushaway, pushing ahead and researching different production techniques for the planned nanotechnology materials. The addition of these techniques is expected to cause changes in formulations, while allowing higher production volumes once commercialized. The company, with API, is viewing the schedule for restarting production given a variety of factors and putting in place improvements for the next generation of Flushaway products. Although there is some delay in restarting production and supply of Flushaway, the overall goal of long-term business success is being maintained and will not be sacrificed as a consequence. The company will hold its annual shareholders meeting on Oct. 31. While the share price is at historic lows, there is no rollback planned and this is not being considered at the AGM. While funds remain limited, the company felt that a debt settlement for the balance sheet, loans from insiders if necessary, the API deal closing shortly and equity financing are all available opinions. The company's annual financials for the year ending June 30, 2007, will be late and not filed as required by the end of October. This will not affect the trading of the company's shares. The company had anticipated that the API transaction would have been closed and payment for the audit would have been completed. The company feels that the recommencement of manufacturing the Flushaway brand is of highest importance and that money originally allocated for the audit was spent ensuring a successful transfer of technology to API. This decision was made for the long-term benefit of the company. The audit will be completed shortly as a combination of cash, insider loans and shareholder loans are being used to facilitate its completion. The audit will be completed as soon as possible. Also, Ecoprogress Australia, a separate entity from the company, continues to owe close to $100,000. The company is continuing to work with it so that when production restarts, that the company can continue to deliver product to it. Talks are continuing to resolve this payable to the company. We seek Safe Harbor.
CES lost a average of $2M a year
Third Quarter 2007
Revenue for the third quarter totaled $ 5,768 compared with $2,335 in 2006. The lack of sales of goods
was largely due to the inability of the Company to fund the production, especially since $138,000 of debts
had not been paid by the Australian distributor. The cost of goods sold was $Nil (2006: $Nil)
Operation costs for the second quarter were $42,040 (2006:$52,836). This drop was primarily because of
the reduction of design and production costs from $18,564 to $Nil as no design or production was carried
out. Legal fees fell from $10,437 to $Nil because with more stable supplier relationships there was no
need for legal fees. Office supplies and communication fell from $11,337 to $1,939 as economies were
put into place. Travel was much higher in the quarter at $14,105 from ($2,840) largely as a result of the
adjustment to costs in 2006. Consulting fees were up from $15,338 to $26,015 as there are more
operations staff in China now than a year ago.
Sales and marketing costs fell considerably from $152,916 in 2006 to $10,310 in 2007. Of this reduction,
$101,034 was amortization of deferred marketing costs which have now been fully amortized, $15,282 as
a result of the decrease in travel to $Nil as there was little sales activity in the quarter and a reduction in
consulting fees from $34,017 to $10,310 as sales staff were halved.
Overall the general and administration costs fell from $554,863 to $269,930. This considerable reduction
was because of the fall in stock based compensation from $241,372 to $3,088 as no options were issued
in the quarter, a fall in consulting fees from $64,866 to $4,500 as fewer consultants were engaged and a
reduction in management and administration services from $70,217 to $45,529 primarily as a result of the
reduction in employee costs. In addition, shareholder and marketing cost fell from $79,016 to ($19,032)
as no annual general meeting took place in the third quarter of 2007, a settlement of an outstanding bill
which led to a reversal in communication costs and a significant reduction in consulting costs. These
reductions were offset by a rise in professional fees, which rose from $6,095 in 2006 to $38,284 in 2007.
The 2006 figure was lower because of negative legal fees whereas 2007 was higher because of a
payment of $22,324 for the 2006 audit and an accrual of $15,000 for the 2007 audit. In addition the bad
debt provision of $138,000 increased office costs from $57,701 to $175,578.
Research and Development costs fell from $16,632 to $7,362 as there were no consulting costs and
That's right laker without money PYCT like CES goes nowhere.
China won't manufacture with out it otherwise CES would still be in buisness.
So how much revenue did Aprilone take from the 34 billion dollar industry when they had the rights to "Flushaway"?
Lol nothing!!That deal never got of the ground.
How much revenue did CES make?
Sales in the quarter ended June 30, 2006, were $33,530. Sales comprising of $11,145 has been delivered to Envirostar in South Africa and $22,385 were delivered to Dr. Fresh. Although there was a $120,000US licensing fee for the purchase of a territory by Highford Holdings, the revenue will be amortized over the 60 month period of the contract. For the present quarter, sales are $17,013 and an order just sent on August 4 and arriving on August 25 is for $16,692. All sales have gone to Dr. Fresh this quarter. To fulfill the request from Dr. Fresh, orders have been shipped on an as needed basis and thus partial containers have been sent. Sales are conservatively booked and a sale is only booked after product is received by the distributor which is typically about 6 to 8 weeks from production to the customer. Our outstanding accounts payable presently stands at $334,000.
Advertising has been limited to discount coupons at the shelf level by Dr. Fresh over the last 2 years. Past production problems that have limited production have since been rectified. A supply chain with secure reliable product is now in place. Dr. Fresh will begin advertising the FlushawayTM Brand in the upcoming quarter with in-store promotions followed by a larger advertising campaign. A national US cable television advertising program will be dependent on receiving the remaining $2,000,000 from the placement announced February 24, 2006.
Talk was cheap!!!
These agreements offer two profitable revenue streams for CES:
(i) CES will supply specialized materials and a technology package to HKC. This package and materials are required for all flushaway(TM) licensed production and in the first year will generate revenues of at least US$1 million for CES.
(ii) In addition, CES will be able to sell HKC produced flushaway(TM) into the global feminine hygiene market outside of the Territory, yielding strong margins.
The distribution agreement commits HKC to sell US$5 million of flushaway(TM) in the first year. They have earmarked significant funding to ensure this volume is achieved through more than 6,500 stores to which they have direct access.
Michael Ong, VP Asia Business Development for CES states:
"This is the beginning of an exciting business relationship with HKC! The Chinese market offers huge potential in its own right and these agreements enable CES to realize cost effective flushaway(TM) production and enhance our growth plan."
CES manufactures and distributes flushaway(TM), the world's first and only flushable and biodegradable brand of sanitary napkins and panty liners, into world-wide markets estimated to be upwards of $9.0 billion USD.
ON BEHALF OF THE BOARD OF DIRECTORS
http://findarticles.com/p/articles/mi_m0EIN/is_2004_Sept_9/ai_n6187016
Had same problem with many deals CES cut,could never really research them until PYCT came along.
Before PYCT there was AprilOne
http://findarticles.com/p/articles/mi_pwwi/is_200708/ai_n19427532
http://finance.sfgate.com/hearst?Account=sfgate&GUID=2870762&Page=MediaViewer&Ticker=CES
This transaction is aimed at providing financial benefit to Ecoprogress by reducing the demand on limited Company resources. It will also allow Flushaway® to more efficiently finance product manufacturing and shipping, allowing Ecoprogress to focus on marketing and distribution of product in its current markets. Certain CET personnel will either move or be seconded to API as part of this agreement.
The story is an old story!!
http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_29/ai_n15882313
http://www.flushaway.com/news/p102604.html
http://www.napiere.com/pdf/newspdf/news19990112.pdf
These unique properties are a major technological breakthrough which can solve some of the most concerning
environmental problems of today. Ecoprogress and its licensor have used the B-9™ film to develop certain
products for the following broad target markets:
1. Disposable Absorbent Products
• Diapers for infants.
• Feminine hygiene products, -- Maxi-pads, panty-liners, etc.
• Diaper shields and underpads for incontinence.
• Wound care dressings.
• Disposable garments used in hospitals and dental offices.
The technology can also be adapted through the use of certain resins which lend themselves to injection moulding
or thermo-forming processes to produce bottles, containers, or trays that maintain their integrity in contact with
cold water but will completely dissolve if submerged in hot water. The unique property of B-9™ is used to
advantage the following sector:
2. Disposable Container Products
3. Containment pouches for urine and fecal matter by persons suffering incontinence during surgery or by the
disabled.
4. Pill bottles, syringes and similar container products.
5. Packaging for cosmetic preparation.
6. Replacement for virtually any plastic packaging.
Napier's management believes the market potential for such products is so significant that it has taken an
aggressive approach to securing significant exposure for its shareholders to this innovative technology. The first
product which has hit the retail stores with remarkable participation at the entry level is a broad line of feminine
hygiene products. Marketed under the brand name "Simplicities®" Ecoprogress has developed the first fully
flushable and biodegradable sanitary napkin. So successful is the design of the product that in 1996 it was
awarded the highly acclaimed Environmental Choice EcologoM Certification for the flushable and biodegradable
sanitary napkin. In order to achieve this status, the product underwent rigorous testing to ensure compliance with
licensing criteria.
CES had a hard time raising funds after years and years of promises eventually the Billion$$ market story got old.
But I see the story got legs again with PYCT and Tom Hands again working the phones...lol
What he say about where they money will come from?
Financing is a key component in the company's growth. The company recently received $1,000,000 from the placement previously announced February 24, 2006. With the stock price below the placement price and the recent Wal-Mart delisting, it is a possibility the balance outstanding of the placement may be cancelled. Although assurances from the placees that funds will be released, the company is committed to moving its business forward in a timely fashion. To ensure this, the company will self-impose a definitive deadline of August 25, 2006 as a cutoff for the funds. If the funds are not received by this day, we will cancel the remaining placement and the shares will be returned to treasury. The shares outstanding would decrease from 82,040,264 shares issued and outstanding down to 62,040,264 shares issued outstanding. Various finance groups have approached the company regarding alternative sources of financing should the other be cancelled. These include equity, inventory and purchase order financing.
http://www.marketwire.com/mw/release.do?id=608314&k=
dcjr!! You got too be kidding when you say "Procter and Gambel is not a R&D company nor is Kimberly-Clark"
http://www.pgbioscience.com/
https://secure3.verticali.net/pg-connection-portal/ctx/noauth/0_0_1_4_83_4_5.do
With 28 Research & Development facilities on four continents, and more than 300 brands in more than 160 countries, connecting with P&G allows you to tap into unparalleled innovation opportunities, global distribution and worldwide marketing assets.
Do you have any clue what you posting???
http://www.allbusiness.com/manufacturing/food-manufacturing-grain-oilseed-milling/334951-1.html
Does it really matter how many projects he was involved in?
He was as I pointed out earlier involved in CES and that flopped...here read this great story.
http://www.flushaway.com/news/pdf/070505.pdf
What he saying about why CES failed?
I never met an IR guy who didn't beleive whatever stock he paid to promote wasn't the next best thing to sliced bread.
How much money will PYCT need to get this started again?
IMO...3-4-5 M$ easy
What he say?
and where will it come from?
http://www.patentstorm.us/patents/5415643/description.html
one reason why the major player aren't interested in this flushable tech is they got thier own,otherwise picking up this one for 5m would be a no brainer.
All they got to do is send KC a diaper and bingo they in a 34Billion a YEAR buisness.Didn't CES think of that ince in the last 8 years...lol
http://www.edb.gov.sg/edb/sg/en_uk/index/news_room/news/2004/kimberly_clark_opens.html
http://www.google.ca/search?sourceid=navclient&ie=UTF-8&rlz=1T4GGIH_enCA231CA232&q=Disposable+diapers+Kimberly%2dClark
This has all been discussed on another BB years ago...lol and they all got it in the teeth beleiving.
The stock ran up from 5 to 55 with some crafty NR's and email blasts of them NR's and back down to 5.
Who you guys calling IR?
Who Tom Hands?
http://infoventure.tsx.com/TSXVenture/TSXVentureHttpController?GetPage=CompanySummary&PO_ID=11651&HC_FLAG1=on&HC_FLAG2=on
Tom Hands knows the drill he's been IR for CES.
Ask him how many shares he getting paid this time?
What do you expect them to tell you other then it's going to the moon!!
so many great stores of instant richess
http://www.inda.org/period/vnews/sep04.pdf
http://www.thefreelibrary.com/CES+Secures+Chinese+Manufacturing+and+Distribution+Agreements+for...-a0121755718
and then
http://www.flushaway.com/news/p102604.html
A patent that would cost them 5Million over 4 years!!
Any one of them major player could give them 5M$ in 4 minutes.
What you missing is that they may be worth squat,that they got thier own material.
CES has had that patent for 8-9 years meanwhile I doubt the major players have been sleeping in that Bio dept.
lol...they probably spend about 5M$ a year on R&D on Biotech materials.many thought that they were waiting for CES to go broke for them to step in and scoop it up cheap...well CES is broke and another broke company got the goods...lol
http://www.flushaway.com/news/pdf/070505.pdf
Here you got some interesting reading but that all it ever was just a good stock story
What I don't understand is how all the major players in this industry ie:Proctor,J&J,KC would let this 34Billion$ a year market slip through thier radar? Anyone one of them could have this on shelves within months with advertising to boot.
ROI would be instant...lol
Afterall this magic stuff is no secret too these major players!!
34Billion is big $$$
http://www.allbusiness.com/company-activities-management/research-development/8707570-1.html
http://siliconinvestor.advfn.com/subject.aspx?subjectid=27292
http://www.nonwovens-industry.com/articles/2000/01/all-that-jazz
PYCT will need 3-4Million just to get this going..